Bethesda, Maryland, United States BroadOak Capital Partners appeared to be the VC, which was created in 2006. The main office of represented VC is situated in the Bethesda. The venture was found in North America in United States.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the BroadOak Capital Partners, startups are often financed by Ben Franklin Technology Partners of Southeastern Pennsylvania, Z80 Labs Technology Incubator, Rand Capital. The meaningful sponsors for the fund in investment in the same round are Research Corporation Technologies, Oxford Finance LLC, Northpond Ventures. In the next rounds fund is usually obtained by Brooks Automation.
Among the most successful fund investment fields, there are Life Science, Pharmaceutical. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Empire Genomics, Rubicon Genomics, Halo Labs.
The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 42 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2016. The fund is generally included in less than 2 deals every year.
Related Funds
| Fund Name | Location |
| 2U Consulting | Bayern, Germany, Nuremberg |
| Dauphin Capital Partners | New York, New York, United States |
| Dongrong Ziben | China, Ningbo, Zhejiang |
| Drive by DraftKings | Boston, Massachusetts, United States |
| East Midlands Business Angels | Newark Upon Trent, Nottinghamshire, United Kingdom |
| Global Atlantic | Atlanta, Georgia, United States |
| Hypersphere Ventures | - |
| Insight | China, Shanghai |
| Kokuyo | Japan, Osaka, Osaka Prefecture |
| Kyoto Chuo Shinkin Bank | Japan, Kyoto, Kyoto Prefecture |
| Leadiant Biosciences | Gaithersburg, Maryland, United States |
| Magellan Health Services | Avon, Connecticut, United States |
| Melo7 Tech Partners | New York, New York, United States |
| Moxxie Ventures | California, San Francisco, United States |
| Redbrick | British Columbia, Canada, Victoria |
| Ridgebox | Astoria, New York, United States |
| Spartech Ventures | Dubai, United Arab Emirates |
| SteelBridge Laboratories | Pennsylvania, Pittsburgh, United States |
| TIBCORP | Central, Central Region, Singapore |
| Wit Capital | New York, New York, United States |
Discover 4 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
S2 Genomics | $16M | 23 Jan 2024 | California, United States | ||
Halo Labs | $7M | 11 Jul 2022 | Philadelphia, Pennsylvania, United States | ||
seqWell | $7M | 29 Mar 2022 | Beverly, Massachusetts, United States | ||
Genomenon | $20M | 08 Mar 2022 | Ann Arbor, Michigan, United States | ||
Genomenon | $5M | 16 Mar 2021 | Ann Arbor, Michigan, United States | ||
Halo Labs | $12M | 06 Apr 2020 | Philadelphia, Pennsylvania, United States | ||
seqWell | $9M | 14 Jan 2020 | Beverly, Massachusetts, United States | ||
InFuse Holdings | $8M | 06 Nov 2019 | Bethesda, Maryland, United States | ||
Codex DNA | $25M | 09 Sep 2019 | San Diego, California, United States |
– PBS Biotech from Camarillo, CA is a manufacturer of single-use bioreactor systems.
– The company closed a $10M funding round.
– The investment was led by BroadOak Capital Partners.
– The new investment will be used to expand and industrialize the company’s portfolio of single-use bioreactor systems and contract process development services.
– BroadOak Capital Partners has invested in KromaTiD.
– KromaTiD’s sales and operations are rapidly accelerating, driven by growing market adoption of their products and services, such as the recently launched dGH In-Site™ and dGH SCREEN™ products for gene editing and gene therapy applications.
– This capital will be used to accelerate commercialization, support ongoing product development, and to increase capacity to meet growing demand.
– KromaTiD’s directional Genomic Hybridization™, or dGH™, today provides the genomic structural context necessary to optimize gene editing strategies for research and clinical purposes, such as therapeutic gene editing based on CRISPR technologies, requiring measurements that can only be made with a single cell, genome-wide analysis provided by dGH™.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
S2 Genomics | $16M | 23 Jan 2024 | California, United States | ||
Halo Labs | $7M | 11 Jul 2022 | Philadelphia, Pennsylvania, United States | ||
seqWell | $7M | 29 Mar 2022 | Beverly, Massachusetts, United States | ||
Genomenon | $20M | 08 Mar 2022 | Ann Arbor, Michigan, United States | ||
Genomenon | $5M | 16 Mar 2021 | Ann Arbor, Michigan, United States | ||
Halo Labs | $12M | 06 Apr 2020 | Philadelphia, Pennsylvania, United States | ||
seqWell | $9M | 14 Jan 2020 | Beverly, Massachusetts, United States | ||
InFuse Holdings | $8M | 06 Nov 2019 | Bethesda, Maryland, United States | ||
Codex DNA | $25M | 09 Sep 2019 | San Diego, California, United States |
